open access

Vol 65, No 9 (2007)
Other
Published online: 2007-10-03
Submitted: 2012-12-28
Get Citation

Original article
Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions

Paweł Buszman, Stanisław Trznadel, Aleksander Żurakowski, Krzysztof Milewski, Leszek Kinasz, Marek Król, Marek Kondys
Kardiol Pol 2007;65(9):1041-1046.

open access

Vol 65, No 9 (2007)
Other
Published online: 2007-10-03
Submitted: 2012-12-28

Abstract

Background: Cobalt-chromium (Co-Cr) stents are a new type of endovascular prostheses characterised by better mechanical properties than traditional stainless steel stents.
Aim: To assess the safety and efficacy of percutaneous coronary interventions (PCI) using the new Co-Cr Kos stent (Balton, Poland).
Methods: A total of 59 patients with coronary artery diseases (76% men, aged 60±9 years, diabetes – 16.9%, smoking – 62.7%, 11.8% – acute myocardial infarction) underwent PCI for de novo lesions in native coronary vessels. The patients were followed for 6 months for the occurrence of cardiac events. Quantitative coronary angiography was performed at baseline and after 6 months.
Results: In total, we implanted 62 stents in 59 coronary arteries. The mean diameter of the stents was 3.18±0.18 mm, and length – 14.62±2.12 mm. During a one-month follow-up period no cardiac events were noted. During a 6-month follow-up no death or new myocardial infarction were recorded. Control angiography was done in 55 (92%) subjects. Repeated target vessel revascularisation due to recurrent angina or in-stent restenosis was required in 10 (17%) patients; however, off-line core evaluation found significant re-narrowing in implanted stents (>50% diameter stenosis) only in 6 cases (10.9%). The mean late vessel lumen loss was 0.55±0.6 mm and stenosis 25.2±17.9%.
Conclusions: Implantation of the new Co-Cr Kos stent during PCI is safe and effective.

Abstract

Background: Cobalt-chromium (Co-Cr) stents are a new type of endovascular prostheses characterised by better mechanical properties than traditional stainless steel stents.
Aim: To assess the safety and efficacy of percutaneous coronary interventions (PCI) using the new Co-Cr Kos stent (Balton, Poland).
Methods: A total of 59 patients with coronary artery diseases (76% men, aged 60±9 years, diabetes – 16.9%, smoking – 62.7%, 11.8% – acute myocardial infarction) underwent PCI for de novo lesions in native coronary vessels. The patients were followed for 6 months for the occurrence of cardiac events. Quantitative coronary angiography was performed at baseline and after 6 months.
Results: In total, we implanted 62 stents in 59 coronary arteries. The mean diameter of the stents was 3.18±0.18 mm, and length – 14.62±2.12 mm. During a one-month follow-up period no cardiac events were noted. During a 6-month follow-up no death or new myocardial infarction were recorded. Control angiography was done in 55 (92%) subjects. Repeated target vessel revascularisation due to recurrent angina or in-stent restenosis was required in 10 (17%) patients; however, off-line core evaluation found significant re-narrowing in implanted stents (>50% diameter stenosis) only in 6 cases (10.9%). The mean late vessel lumen loss was 0.55±0.6 mm and stenosis 25.2±17.9%.
Conclusions: Implantation of the new Co-Cr Kos stent during PCI is safe and effective.
Get Citation

Keywords

coronary artery disease; stent; PTCA; restenosis

About this article
Title

Original article
Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 65, No 9 (2007)

Pages

1041-1046

Published online

2007-10-03

Bibliographic record

Kardiol Pol 2007;65(9):1041-1046.

Keywords

coronary artery disease
stent
PTCA
restenosis

Authors

Paweł Buszman
Stanisław Trznadel
Aleksander Żurakowski
Krzysztof Milewski
Leszek Kinasz
Marek Król
Marek Kondys

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl